↓ Skip to main content

Genetic lesions and targeted therapy in Hodgkin lymphoma

Overview of attention for article published in Therapeutic Advances in Hematology, January 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genetic lesions and targeted therapy in Hodgkin lymphoma
Published in
Therapeutic Advances in Hematology, January 2023
DOI 10.1177/20406207221149245
Pubmed ID
Authors

Zhe Li, Wei Mu, Min Xiao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 14%
Student > Ph. D. Student 1 14%
Other 1 14%
Unknown 4 57%
Readers by discipline Count As %
Medicine and Dentistry 2 29%
Immunology and Microbiology 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#15,862,459
of 23,572,442 outputs
Outputs from Therapeutic Advances in Hematology
#210
of 309 outputs
Outputs of similar age
#232,709
of 437,055 outputs
Outputs of similar age from Therapeutic Advances in Hematology
#9
of 10 outputs
Altmetric has tracked 23,572,442 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 309 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,055 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one.